Search Results - "proteomics"
Suggested Topics within your search.
Suggested Topics within your search.
- Biochemical markers
- Biomarkers 30
- Proteomics 25
- methods 21
- Methodology 20
- analysis 12
- diagnosis 11
- Diseases 9
- Proteome 9
- Cardiovascular Diseases 8
- Analysis 6
- Cancer 6
- Cardiovascular system 6
- Kidney Diseases 6
- Kidneys 6
- Molecular Diagnostic Techniques 6
- Molecular diagnosis 6
- Diagnosis 5
- Alzheimer Disease 3
- Alzheimer's disease 3
- Bacterial Infections 3
- Bacterial diseases 3
- Bladder 3
- Degeneration 3
- Diagnostic use 3
- Drug Resistance, Microbial 3
- Glycomics 3
- Lipid Metabolism 3
- Lipids 3
- Macrophages 3
-
1
The proteomic revolution
Published 2012Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
2
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
3
The proteomic revolution
Published 2022Table of Contents: “…Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine.…”
Get full text
Series
Electronic Video -
4
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
5
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
6
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
7
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
8
Proteomics in cardiovascular disease clinical considerations /
Published 2013Table of Contents: “…Contents: Systems biology -- Definition of proteomics -- Proteomics: rationale and practical aspects -- Proteomics in cardiovascular pathophysiology -- Proteomics to detect biomarkers of cardiovascular disease -- Urinary proteomics using capillary electrophoresis / mass spectrometry -- Proteomics of coronary artery disease -- Proteomics of pre-eclampsia -- Proteomics of other cardiovascular diseases: stroke, heart failure, diabetic nephropathy.…”
Get full text
Series
Electronic Video -
9
Proteomics in kidney disease clinical considerations /
Published 2013Table of Contents: “…Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
10
A concept for multi-marker approaches in clinical proteomics
Published 2013Subjects: Get full text
Series
Electronic Video -
11
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
12
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
13
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
14
Clinical proteomics in neurodegenerative disease
Published 2013Table of Contents: “…Contents: Neurodegenerative disease -- Dementia -- Alzheimer´s -- Clinical use of proteomic methods for diagnosis and biomarker development -- An example: CE-MS in Alzheimer research -- Scope, limits, pitfalls, prospects.…”
Get full text
Series
Electronic Video -
15
A concept for multi-marker approaches in clinical proteomics
Published 2013Subjects: Get full text
Series
Electronic Video -
16
A concept for multi-marker approaches in clinical proteomics
Published 2013Subjects: Get full text
Series
Electronic Video -
17
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
18
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video -
19
Urinary proteomics in kidney and cardiovascular disease
Published 2013Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)
Electronic Video -
20
Clinical proteomics in the investigation of bladder cancer
Published 2013Table of Contents: “…Contents: Clinical proteomics: principles of experimental design and data reporting -- Clinical needs in bladder cancer -- Bladder Cancer Biomarker discovery in urine using proteomics approaches -- How to progress towards implementation.…”
Get full text
Series
Electronic Video